Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anxiety and Depression in Psoriasis Patients

Psoriasis patient with low socioeconomic status (SES) suffer from more severe courses of anxiety and depression, a new study found. The nationwide population-based study included 255,862 psoriasis patients who were age and gender frequency matched to controls. Outcome measures were the association between psoriasis and anxiety, depression, and anxiety-depression co-occurrence among patients according to their SES. Researchers found:

  • After controlling for variables, psoriasis was associated with anxiety, depression, and anxiety-depression co-occurrence among patients with low SES.
  • However, psoriasis was associated only with anxiety but not depression or comorbid anxiety-depression among those with high SES.
  • Survival analyses indicated that between the ages of 40 and 60, the cumulative probability of psoriasis patients with low SES to suffer from anxiety, depression, and their co-occurrence inclined more sharply with age as compared to psoriasis patients with high SES.

Citation:

Tzur Bitan D, Krieger I, Comaneshter, et al. The association between the socioeconomic status and anxiety-depression comorbidity in patients with psoriasis: A nationwide population-based study. [Published online ahead of print May 4, 2019]. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.15651.